| | Business Summary | | Diapulse
Corporation
of
America
develops,
manufactures,
and
markets
Diapulse
Technology,
a
proprietary
medical
system
that
produces
non-thermal
pulsed
high
frequency,
high
peak
power
electromagnetic
energy
to
treat
post-operative
edema
and
pain
in
acute
and
chronic
wounds.
Diapulse
Technology
is
used
in
hospitals,
nursing
facilities,
outpatient
clinics,
physician's
practice
and
by
prescription
in
patients'
homes.
The
Company
rents
and
sells
Diapulse
units
to
hospitals,
nursing
homes,
physicians,
and
rents
its
equipment
to
patients
covered
by
Medicare
and
private
insurance
companies. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | DIAC
develops,
manufactures
and
markets
Diapulse
Technology,
a
proprietary
medical
system
which
produces
non-thermal
pulsed
high-frequency,
high
peak
power
electromagnetic
energy
to
treat
post-operative
edema
and
pain
in
acute
and
chronic
wounds.
For
the
six
months
ended
6/30/01,
revenues
rose
15%
to
$897
thousand.
Net
loss
totalled
$56
thousand
vs.
income
of
$262
thousand.
Revenues
reflect
decreased
sales
and
rentals.
Loss
reflects
increased
S/G/A
expenses. | | More
from
Market Guide: Significant
Developments |
| | Officers | |
| Position | | Jesse Ross, 79 | Chairman,
Pres |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/d/diac.ob.gif)